Advanced search
Publication Cover
Journal of Blood Medicine Volume 11, 2020 - Issue
Submit an article Journal homepage
90
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency

Skye Peltier1 Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center - Fairview, Minneapolis, MN, USACorrespondence[email protected]
,
Angela Kellum2 Louisiana Center for Bleeding and Clotting Disorders, Tulane University, New Orleans, LA, USAORCID Iconhttps://orcid.org/0000-0002-1770-6160
ORCID Icon,
Janet Brewer3 Comprehensive Health Education Services, Hanson, MA, USA
,
Alexander Duncan4 Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA
,
David L Cooper5 Novo Nordisk Inc., Plainsboro, NJ, USAORCID Iconhttps://orcid.org/0000-0002-4499-1526
ORCID Icon &
Hossam Saad5 Novo Nordisk Inc., Plainsboro, NJ, USA
Pages 297-303 | Published online: 11 Sep 2020

References

  • Franchini M, Marano G, Mengoli C, et al. Inhibitors in patients with congenital bleeding disorders other than hemophilia. Semin Thromb Hemost.;44(6):595–603. doi:10.1055/s-0037-1607441
  • Jain S, Donkin J, Frey MJ, Peltier S, Gunawardena S, Cooper DL. Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic. J Blood Med. 2018;9:211–218. doi:10.2147/JBM.S15763330510462
  • Shahbazi S, Mahdian R. Factor VII gene defects: review of functional studies and their clinical implications. Iran Biomed J. 2019;23(3):165–174. doi:10.29252/ibj.23.3.16530797223
  • Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thrombosis Haemostasis. 2012;10(4):615–621. doi:10.1111/j.1538-7836.2012.04653.x
  • Napolitano M, Siragusa S, Mariani G. Factor VII deficiency: clinical phenotype, genotype and therapy. J Clin Med. 2017;6:4. doi:10.3390/jcm6040038
  • de Moerloose P, Schved JF, Nugent D. Rare coagulation disorders: fibrinogen, factor VII and factor XIII. Haemophilia. 2016;22(Suppl 5):61–65. doi:10.1111/hae.1296527405678
  • Mariani G, Bernardi F. Factor VII deficiency. Semin Thromb Hemost. 2009;35(4):400–406. doi:10.1055/s-0029-122576219598068
  • Hedner U. Recombinant activated factor VII: 30 years of research and innovation. Blood Rev. 2015;29(Suppl 1):S4–8. doi:10.1016/S0268-960X(15)30002-326073368
  • Loddo A, Cornacchia S, Cane FL, et al. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: a case report and literature review. Eur J Obstet Gynecol Reprod Biol. 2019;235:77–80. doi:10.1016/j.ejogrb.2019.02.01730831446
  • Rajpurkar M, Croteau SE, Boggio L, Cooper DL. Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC). J Blood Med. 2019;10:335–340. doi:10.2147/JBM.S21957331572039
  • Novo Nordisk Inc. NovoSeven®RT Package Insert. 2019.
  • Rodeghiero F, Tosetto A, Abshire T, et al. on behalf of the ISTH/SSC Joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC Bleeding Assessment Tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thrombosis Haemostasis. 2010;8(9):2063–2065. doi:10.1111/j.1538-7836.2010.03975.x.
  • Elbatarny M, Mollah S, Grabell J, et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831–835. doi:10.1111/hae.1250325196510
  • Page D. Comprehensive care for hemophilia and other inherited bleeding disorders. Transfusion Apheresis Sci. 2019;58(5):565–568. doi:10.1016/j.transci.2019.08.005
  • Bannow BS, Konkle BA. Inherited bleeding disorders in the obstetric patient. Transfus Med Rev. 2018;32(4):237–243. doi:10.1016/j.tmrv.2018.06.00330097224
  • Napolitano M, Giansily-Blaizot M, Dolce A, et al. Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER). Haematologica. 2013;98(4):538–544. doi:10.3324/haematol.2012.07403923403322
  • Holve S, Stuart R, Recht M. Prophylaxis of recurrent epistaxis and menorrhagia using recombinant factor VIIa in severe congenital factor VII deficiency. Pediatr Res. 2001;49(4):203A.11158514
  • Huth-Kuhne A, Lages P, Zimmerman R. Regular prophylaxis with recombinant factor VIIa in a patient with severe congenital FVII deficiency. Hämostaseologie. 2008;28(Suppl S 01):S55. doi:10.1055/s-0037-1617127
  • Napolitano M, Di Minno MN, Batorova A, et al. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies. Haemophilia. 2016;22(5):752–759. doi:10.1111/hae.1297827338009
  • Mariani G, Herrmann FH, Dolce A, et al. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005;93(3):481–487. doi:10.1160/TH04-10-065015735798
  • National Hemophilia Foundation. MASAC recommendations concerning products licensed for the treatment of hemophilia and other bleeding disorders; 2020 Available from: https://www.hemophilia.org/Researchers-Healthcare-Providers/Medical-and-Scientific-Advisory-Council-MASAC/MASAC-Recommendations/MASAC-Recommendations-Concerning-Products-Licensed-for-the-Treatment-of-Hemophilia-and-Other-Bleeding-Disorders. Accessed 324, 2020.
  • Batorova A, Mariani G, Kavakli K, et al. Inhibitors to factor VII in congenital factor VII deficiency. Haemophilia. 2014;20(2):e188–191. doi:10.1111/hae.1237624533960

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.